Pharmaceutical and Life Sciences Deals Insights Quarterly

May 2014
  • Print-friendly version
Pharmaceutical and Life Sciences Deals Insights Quarterly

At a glance

The volume of PLS deals closed in the first quarter of 2014 increased 53.1% to 49 deals, compared with 32 in the fourth quarter of 2013, and increased 40% from 35 deals in the first quarter of 2013. The value of PLS deals closed during the first quarter of 2014 increased 20.9% to $44.9 billion, relative to the approximately $37.2 billion in the fourth quarter of 2013. Recent trends in deal volumes point to increased M&A activity in the coming quarters.

This issue of Pharmaceutical and Life Sciences Deals Insights Quarterly brings you PwC’s perspective on deal activity in the industry and features the following:

Market update: A summary of M&A deals and trends for the previous quarter.

Market spotlight: This issue focuses on India. Despite enormous potential, the PLS market in India is facing significant regulatory changes affecting sales and marketing practices and having an impact on both how clinical trials are conducted and how products are priced in the marketplace.

Strategy corner: Insights from PwC’s 17th Global CEO Survey: Increased optimism — but big changes ahead.

Further reading:

US Pharmaceuticals and Life Sciences Deals Insights Quarterly Q4 2013

US Pharmaceuticals and Life Sciences Deals Insights Quarterly Q3 2013

US Pharmaceuticals and Life Sciences Deals Insights Quarterly Q2 2013

US Pharmaceuticals and Life Sciences Deals Insights Quarterly Q1 2013